http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108157633-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2f7c1629d09127a6ae758aae1a268d8 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-163 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K40-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K10-18 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K40-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K10-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-163 |
filingDate | 2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4827dcbe89f8a1b47b89425a114bf6e |
publicationDate | 2018-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-108157633-A |
titleOfInvention | Pig starter feed microcapsules |
abstract | The invention belongs to field of fodder, and in particular to a kind of pig starter feed microcapsules, the core material of the microcapsules is lactic acid bacteria;Wall material is propylene glycol alginate;The core material of the microcapsules and the ratio of wall material are:0.05‑0.1:1.The preparation method of the microcapsules is:1) preparation of strain fermentating liquid;2) mass fraction is made as 30% 40% aqueous solution in wall material;3) high cut disperse emulsification is carried out after step 1) is mixed with the liquid of step 2), precursor liquid is made;4) solid-state microcapsule granule is made through vacuum atomizing drying in precursor liquid.Micro-encapsulated diet is added in the present invention, using lactic acid bacteria as core material, propylene glycol alginate is wall material;Propylene glycol alginate can be rapidly destroyed in animal intestinal tract, and the lactic acid bacteria of release can take up the field planting point in enteron aisle, and proliferation becomes dominant microflora rapidly, so as to reach the effects that inhibiting growth of pathogenic bacteria. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109527238-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110754580-A |
priorityDate | 2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.